LONG-TERM KINETICS OF HEPATITIS B SURFACE ANTIGEN (HBSAG) DURING NUCLEOS(T)IDE ANALOGUE THERAPY INDICATE THAT FINITE TREATMENT IS UNLIKELY

被引:0
作者
Chevaliez, Stephane [1 ]
Hezode, Christophe [1 ]
Bahrami, Stephane [2 ]
Grare, Marion [1 ]
Pawlotsky, Jean-Michel [1 ]
机构
[1] Henri Mondor Hosp, INSERM, U955, Creteil, France
[2] Univ Paris Est Creteil Val Marne, Paris Hlth Econ & Hlth Serv Res Unit, Creteil, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1082A / 1082A
页数:1
相关论文
共 50 条
  • [41] Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss
    Zimmer, Christine L.
    Rinker, Franziska
    zu Siederdissen, Christoph Hoener
    Manns, Michael P.
    Wedemeyer, Heiner
    Cornberg, Markus
    Bjorkstrom, Niklas K.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (10) : 1656 - 1666
  • [42] Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy
    Velay, A.
    Jeulin, H.
    Eschlimann, M.
    Malve, B.
    Goehringer, F.
    Bensenane, M.
    Frippiat, J-P.
    Abraham, P.
    Ismail, A. M.
    Murray, J. M.
    Combet, C.
    Zoulim, F.
    Bronowicki, J-P.
    Schvoerer, E.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (05) : 387 - 398
  • [43] Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naive patients with chronic hepatitis B
    Wei, Lai
    Kao, Jia-Horng
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (03) : 495 - 504
  • [44] MINIMAL RESIDUAL VIREMIA DURING LONG-TERM THERAPY WITH NUCLEOS(T)IDE ANALOGUES IN PATIENTS WITH CHRONIC HEPATITIS B
    Wiegand, Johannes
    Maier, Melanie
    Liebert, Uwe G.
    Berg, Thomas
    HEPATOLOGY, 2011, 54 : 1086A - 1086A
  • [45] Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
    Papatheodoridis, GV
    Dimou, E
    Dimakopoulos, K
    Manolakopoulos, S
    Rapti, I
    Kitis, G
    Tzourmakliotis, D
    Manesis, E
    Hadziyannis, SJ
    HEPATOLOGY, 2005, 42 (01) : 121 - 129
  • [46] EARLY ON-TREATMENT HBV RNA AND HBCRAG PROFILES PREDICT FAVOURABLE HBsAg SUPPRESSION OR SEROCLEARANCE UPON LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY IN CHRONIC HEPATITIS B INFECTION
    Mak, Lung-Yi
    Wong, Danny
    Kuchta, Alison
    Hilfiker, Martina
    Hamilton, Aaron
    Seto, Wai Kay Walter
    Yuen, Man-Fung
    HEPATOLOGY, 2021, 74 : 433A - 434A
  • [47] The long-term efficacy of combination of nucleos(t)ide analogue treatment and low dose hepatitis b immunoglobulin on posttransplant HBV recurrence
    Idilman, Ramazan
    Akyildiz, Murat
    Keskin, Onur
    Tuzun, Ali
    Yilmaz, Tonguc U.
    Guler, Necdet
    Yaprak, Onur
    Gungor, Gokhan
    Erdogan, Yalcin
    Dayangac, Murat
    Balci, Deniz
    Cinar, Kubilay
    Tuzuner, Acar
    Hazinedaroglu, Selcuk
    Tokat, Yaman
    Ersoz, Sadik
    Dokmeci, Abdulkadir
    HEPATOLOGY, 2014, 60 : 542A - 542A
  • [48] Hepatitis B surface antigen (HBsAg) seroclearance following discontinuation of nucleos (t)ide analogues (NA) treatment has comparable durability to HBsAg seroclearance achieved during NA therapy
    Cheuk-Fung, Terry
    Lai, Mandy Sze-Man
    Lai, Jimmy Che-To
    Tse, Yee-Kit
    Chan, Henry L. Y.
    Wong, Vincent Wai-Sun
    Lai-HungWong, Grace
    JOURNAL OF HEPATOLOGY, 2024, 80 : S761 - S761
  • [49] Adherence to nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B
    Manolakopoulos, Spilios
    Goulis, John
    Striki, Athanasia
    Deutsch, Melanie
    Perlepe, Nikoleta
    Triantos, Christos
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2015, 148 (04) : S1068 - S1068
  • [50] Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan
    Fumitaka Suzuki
    Tetsuya Hosaka
    Yoshiyuki Suzuki
    Hitomi Sezaki
    Norio Akuta
    Shunichiro Fujiyama
    Yusuke Kawamura
    Masahiro Kobayashi
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Rie Mineta
    Yukiko Suzuki
    Hiromitsu Kumada
    Journal of Gastroenterology, 2019, 54 : 182 - 193